ABILITY PHARMA Trademark

Trademark Overview


On Monday, September 30, 2024, a trademark application was filed for ABILITY PHARMA with the United States Patent and Trademark Office. The USPTO has given the ABILITY PHARMA trademark a serial number of 79416504. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Wednesday, October 22, 2025. This trademark is owned by ABILITY PHARMACEUTICALS, S.A.. The ABILITY PHARMA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical products for the treatment of cancer

Scientific and technological research activities for development of new drugs and medicines; Technical consultancy in the field of pharmaceutical studies, in particular relating to evaluations, estimates, and reports prepared in the course of scientific and technological research in the field of pharmaceutical medicines; Industrial analysis, namely, analysis of pharmacokinetics, pharmacodynamics and biomarkers related to drugs and medicines or pathologies to assure compliance with industry standards; Industrial research in the field of medicine
ability pharma

General Information


Serial Number79416504
Word MarkABILITY PHARMA
Filing DateMonday, September 30, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateWednesday, October 22, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


NOT AVAILABLE"PHARMA"
Goods and ServicesPharmaceutical products for the treatment of cancer
Goods and ServicesScientific and technological research activities for development of new drugs and medicines; Technical consultancy in the field of pharmaceutical studies, in particular relating to evaluations, estimates, and reports prepared in the course of scientific and technological research in the field of pharmaceutical medicines; Industrial analysis, namely, analysis of pharmacokinetics, pharmacodynamics and biomarkers related to drugs and medicines or pathologies to assure compliance with industry standards; Industrial research in the field of medicine

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 19, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, February 19, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameABILITY PHARMACEUTICALS, S.A.
Party Type10 - Original Applicant
Legal Entity Type85 - NOT AVAILABLE
AddressES

Trademark Events


Event DateEvent Description
Thursday, February 6, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, February 19, 2025LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, February 21, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 21, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, March 19, 2025ASSIGNED TO EXAMINER
Monday, March 24, 2025NON-FINAL ACTION WRITTEN
Tuesday, March 25, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, May 16, 2025REFUSAL PROCESSED BY MPU
Saturday, May 17, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, June 7, 2025REFUSAL PROCESSED BY IB
Monday, October 20, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 20, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 22, 2025TEAS/EMAIL CORRESPONDENCE ENTERED